Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of Interim PET-MRI in High-grade Glioma Patients Undergoing Chemoradiation

NCT05212272 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT05212272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05212272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of Interim PET-MRI in High-grade Glioma Patients Undergoing Chemoradiation
Lead sponsor
Wake Forest University Health Sciences
Phase
Not applicable
Overall status
Recruiting
Start date
September 2, 2022
Completion date
December 31, 2027
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high grade glioma